1,959
Views
9
CrossRef citations to date
0
Altmetric
Clinical Study

Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis

, , , , , & show all
Pages 1654-1658 | Received 21 Apr 2016, Accepted 20 Aug 2016, Published online: 19 Oct 2016

References

  • Hedayati S. Dialysis-related carnitine disorder. Semin Dial. 2006;19:323–328.
  • Reuter SE, Faull RJ, Ranieri E, et al. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic hemodialysis patients. Nephrol Dial Transplant. 2009;24:990–996.
  • Bene J, Csiky B, Komlosi K, Sulyok E, Melegh B. Dynamic adaptive changes of the serum carnitine esters during and after l-carnitine supplementation in patients with maintenance haemodialysis. Scand J Clin Lab Invest. 2011;71:280–286.
  • Chen XM. Blood hemodialysis. In: Ding XQ, Liu FY, Liu ZH, Chen JH, Mei CL, editors. Purification Standard Operating Procedure (SOP). Chapter 10. Beijing, China: People’s Military Medical Press; 2012.
  • Csiky B, Bene J, Wittmann I, Sulyok E, Melegh B. Effect of hemodialysis session on the dynamics of carnitine ester profile changes in l-carnitine pretreated end-stage renal disease patients. Int Urol Nephrol. 2013;45:847–855.
  • Bene J, Csiky B, Wittmann I, Sulyok E, Melegh B. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients. Ren Fail. 2012;34:555–558.
  • Reuter SE, Evans AM. Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet. 2012;51:553–572.
  • Kudoh Y, Aoyama S, Torii T, et al. Hemodynamic stabilizing effects of l-carnitine in chronic hemodialysis patients. Cardiorenal Med. 2013;3:200–207.
  • Evans AM, Faull RJ, Nation RL, et al. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney Int. 2004;66:1527–1534.
  • Schreiber BD. Debate forum: Levocarnitine therapy is rational and justified in selected dialysis patients. Blood Purif. 2006;24:128–134.
  • Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and hemodialysis. Am J Kidney Dis. 2003;41:S116–S122.
  • Bohomini M. Pharmacological use of l-carnitine in uremic anemia: Has its full potential been exploited? Pharmacol Res. 2011;63:157–164.
  • Marcovina SM, Sirtori C, Peracino A, et al. Translating the basic knowledge of mitochondrial functions to metabolic therapy: Role of l-carnitine. Transl Res. 2013;161:73–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.